Conversely, in the 19 hematological cancer cell lines, we did not observe higher sensitivity associated with MYC alterations (amplified, driver‐mutated, translocated; Fig EV2B and C). The gene discussed is MYC; the disease is hematopoietic and lymphoid cell neoplasm.